Kyle RA - Search Results

1

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, Dispenzieri A, Fonseca R, Sher T, Kyle RA, Lin Y, Russell SJ, Kumar S, Bergsagel PL, Zeldenrust SR, Leung N, Drake MT, Kapoor P, Ansell SM, Witzig TE, Lust JA, Dalton RJ, Gertz MA, Stewart AK, Rajkumar SV, Chanan-Khan A, Lacy MQ; Mayo Clinic. Mikhael JR, et al. Among authors: kyle ra. Mayo Clin Proc. 2013 Apr;88(4):360-76. doi: 10.1016/j.mayocp.2013.01.019. Mayo Clin Proc. 2013. PMID: 23541011

2

Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type.

Kyle RA, Gertz MA, Linke RP. Kyle RA, et al. Am J Clin Pathol. 1992 Feb;97(2):250-3. doi: 10.1093/ajcp/97.2.250. Am J Clin Pathol. 1992. PMID: 1372147

3

Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period.

Gertz MA, Kyle RA, Thibodeau SN. Gertz MA, et al. Among authors: kyle ra. Mayo Clin Proc. 1992 May;67(5):428-40. doi: 10.1016/s0025-6196(12)60388-7. Mayo Clin Proc. 1992. PMID: 1405768

4

Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.

Gertz MA, Kyle RA, O'Fallon WM. Gertz MA, et al. Among authors: kyle ra. Arch Intern Med. 1992 Nov;152(11):2245-50. Arch Intern Med. 1992. PMID: 1444684

5

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.

Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O'Fallon WM, Kurland LT. Kyle RA, et al. Blood. 1992 Apr 1;79(7):1817-22. Blood. 1992. PMID: 1558973 Free article.

6

Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis.

Gastineau DA, Gertz MA, Rosen CB, Kyle RA. Gastineau DA, et al. Among authors: kyle ra. Am J Hematol. 1991 Jul;37(3):194-6. doi: 10.1002/ajh.2830370312. Am J Hematol. 1991. PMID: 1858771

7

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.

Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Rajkumar S, et al. Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943. Bone Marrow Transplant. 1999. PMID: 10482933

8

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.

Schop RF, Jalal SM, Van Wier SA, Ahmann GJ, Bailey RJ, Kyle RA, Greipp PR, Rajkumar SV, Gertz MA, Lust JA, Lacy MQ, Dispenzieri A, Witzig TE, Fonseca R. Schop RF, et al. Among authors: kyle ra. Cancer Genet Cytogenet. 2002 Jan 1;132(1):55-60. doi: 10.1016/s0165-4608(01)00526-x. Cancer Genet Cytogenet. 2002. PMID: 11801310

9

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. Kyle RA, et al. N Engl J Med. 2002 Feb 21;346(8):564-9. doi: 10.1056/NEJMoa01133202. N Engl J Med. 2002. PMID: 11856795 Free article.

10

Current therapy of multiple myeloma.

Kyle RA. Kyle RA. Intern Med. 2002 Mar;41(3):175-80. doi: 10.2169/internalmedicine.41.175. Intern Med. 2002. PMID: 11929176 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,530 results

Search Page